Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Merker

Showing results (81-90 of 90) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 90 results.
The Lancet. Infectious Diseases|January 13, 2018
A cluster of multidrug-resistant Mycobacterium tuberculosis among patients arriving in Europe from the Horn of Africa: a molecular epidemiological studyTimothy M Walker, Matthias Merker, Astrid M Knoblauch, et al.
The Journal of Antimicrobial Chemotherapy|March 9, 2022
Ancient and recent differences in the intrinsic susceptibility of Mycobacterium tuberculosis complex to pretomanidAnna Bateson, Julio Ortiz Canseco, Timothy D McHugh, et al.
The Lancet. Infectious Diseases|March 3, 2023
Clinical implications of molecular drug resistance testing for Mycobacterium tuberculosis: a 2023 TBnet/RESIST-TB consensus statementJosé Domínguez, Martin J Boeree, Emmanuelle Cambau, et al.
The Lancet. Microbe|July 30, 2022
Investigating resistance in clinical Mycobacterium tuberculosis complex isolates with genomic and phenotypic antimicrobial susceptibility testing: a multicentre observational studyIris Finci, Audrey Albertini, Matthias Merker, et al.
Antimicrobial Agents and Chemotherapy|October 4, 2017
Role of Alanine Racemase Mutations in Mycobacterium tuberculosis d-Cycloserine ResistanceYoshio Nakatani, Helen K Opel-Reading, Matthias Merker, et al.
Wellcome Open Research|February 15, 2020
Antibiotic resistance prediction for <i>Mycobacterium tuberculosis</i> from genome sequence data with MykrobeMartin Hunt, Phelim Bradley, Simon Grandjean Lapierre, et al.
The Lancet. Respiratory Medicine|March 28, 2017
The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosisKeertan Dheda, Tawanda Gumbo, Gary Maartens, et al.
Genes|June 24, 2022
Origin and Global Expansion of <i>Mycobacterium tuberculosis</i> Complex Lineage 3Yassir A Shuaib, Christian Utpatel, Thomas A Kohl, et al.
Nature Genetics|January 20, 2015
Evolutionary history and global spread of the Mycobacterium tuberculosis Beijing lineageMatthias Merker, Camille Blin, Stefano Mona, et al.
The New England Journal of Medicine|October 4, 2018
Prediction of Susceptibility to First-Line Tuberculosis Drugs by DNA Sequencing, Caroline Allix-Béguec, Irena Arandjelovic, et al.
Pageof 9

Showing results (81-90 of 90) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 90 results.
The Lancet. Infectious Diseases|January 13, 2018
A cluster of multidrug-resistant Mycobacterium tuberculosis among patients arriving in Europe from the Horn of Africa: a molecular epidemiological studyTimothy M Walker, Matthias Merker, Astrid M Knoblauch, et al.
The Journal of Antimicrobial Chemotherapy|March 9, 2022
Ancient and recent differences in the intrinsic susceptibility of Mycobacterium tuberculosis complex to pretomanidAnna Bateson, Julio Ortiz Canseco, Timothy D McHugh, et al.
The Lancet. Infectious Diseases|March 3, 2023
Clinical implications of molecular drug resistance testing for Mycobacterium tuberculosis: a 2023 TBnet/RESIST-TB consensus statementJosé Domínguez, Martin J Boeree, Emmanuelle Cambau, et al.
The Lancet. Microbe|July 30, 2022
Investigating resistance in clinical Mycobacterium tuberculosis complex isolates with genomic and phenotypic antimicrobial susceptibility testing: a multicentre observational studyIris Finci, Audrey Albertini, Matthias Merker, et al.
Antimicrobial Agents and Chemotherapy|October 4, 2017
Role of Alanine Racemase Mutations in Mycobacterium tuberculosis d-Cycloserine ResistanceYoshio Nakatani, Helen K Opel-Reading, Matthias Merker, et al.
Wellcome Open Research|February 15, 2020
Antibiotic resistance prediction for <i>Mycobacterium tuberculosis</i> from genome sequence data with MykrobeMartin Hunt, Phelim Bradley, Simon Grandjean Lapierre, et al.
The Lancet. Respiratory Medicine|March 28, 2017
The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosisKeertan Dheda, Tawanda Gumbo, Gary Maartens, et al.
Genes|June 24, 2022
Origin and Global Expansion of <i>Mycobacterium tuberculosis</i> Complex Lineage 3Yassir A Shuaib, Christian Utpatel, Thomas A Kohl, et al.
Nature Genetics|January 20, 2015
Evolutionary history and global spread of the Mycobacterium tuberculosis Beijing lineageMatthias Merker, Camille Blin, Stefano Mona, et al.
The New England Journal of Medicine|October 4, 2018
Prediction of Susceptibility to First-Line Tuberculosis Drugs by DNA Sequencing, Caroline Allix-Béguec, Irena Arandjelovic, et al.
Pageof 9